Molly A. Vickers

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

Gang Ye, Joseph P. Gallant, Jian Zheng et al. · eLife · 2021 · 62 citations · Full text

Exponential increase in neutralizing and spike specific antibodies following vaccination of <scp>COVID</scp> ‐19 convalescent plasma donors

Molly A. Vickers, Alan Sariol, Judith Leon et al. · Transfusion · 2021 · 28 citations · Full text

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2

Gang Ye, Joseph P. Gallant, Christopher Massey et al. · 2020 · 23 citations · Full text

Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood Mycobacterium tuberculosis Specific T Cell Activation and Functional Markers

Molly A. Vickers, Fatoumatta Darboe, Caleb Muefong et al. · Frontiers in Immunology · 2020 · 11 citations · Full text

Waning of Maternal Antibodies against Measles Suggests a Large Window of Susceptibility in Infants in Lao People’s Democratic Republic

Phonepaseuth Khampanisong, Maude Pauly, Phonethipsavanh Nouanthong et al. · Pathogens · 2021 · 10 citations · Full text